On 19 March 2020, Medtronic plc (NYSE: MDT) changed 6.28% to recent value of $79.22. The stock transacted 11112032 shares during most recent day however it has an average volume of 5878.73K shares. It spotted trading -35.14% off 52-week high price. On the other end, the stock has been noted 9.83% away from the low price over the last 52-weeks.
Medtronic plc (MDT) recently reported financial results for its third quarter of fiscal year 2020, which ended January 24, 2020.
The company stated third quarter worldwide revenue of $7.717B, a raise of 2.3 percent as stated and 2.6 percent on an organic basis, which adjusts for a $46M negative impact from foreign currency and a $21M contribution from the company’s acquisition of Titan Spine, which is stated in the Spine division in the Restorative Therapies Group. As stated, third quarter GAAP net income and diluted earnings per share (EPS) were $1.915B and $1.42, respectively. As detailed in the financial schedules included through the link at the end of this release, third quarter non-GAAP net income and non-GAAP diluted EPS were $1.949B and $1.44, respectively, increases of 11.3 percent and 11.6 percent, respectively.
Third quarter U.S. revenue of $4.021B represented 52 percent of company revenue and increased 0.5 percent as stated. Non-U.S. developed market revenue of $2.377B represented 31 percent of company revenue and increased 0.4 percent as stated and 1.5 percent constant currency. Emerging Markets revenue of $1.318B represented 17 percent of company revenue and increased 12.0 percent as stated and 13.6 percent constant currency.
“Organic revenue growth was light this quarter, due largely to transient issues,” stated Omar Ishrak, Medtronic chairman and chief executive officer. “However, we continue to feel very good about the fourth quarter, and in the third quarter, a softer top-line was over offset by important margin expansion, resulting in better-than-predictable earnings per share and free cash flow.”
MDT has a gross margin of 69.50% and an operating margin of 17.80% while its profit margin remained 17.10% for the last 12 months. Its earnings per share (EPS) expected to touch remained -13.10% for this year while earning per share for the next 5-years is expected to reach at 6.86%. The company has 1467.83M of outstanding shares and 1339.22M shares were floated in the market. According to the most recent quarter its current ratio was 2.8 that represents company’s ability to meet its current financial obligations. The price moved ahead of -18.63% from the mean of 20 days, -27.87% from mean of 50 days SMA and performed -25.93% from mean of 200 days price. Company’s performance for the week was -6.14%, -30.37% for month and YTD performance remained -30.17%.